X4 Pharmaceuticals, Inc. (XFOR)
NASDAQ: XFOR · Real-Time Price · USD
3.120
-0.050 (-1.58%)
Nov 13, 2026, 4:00 PM EST - Market closed
X4 Pharmaceuticals Market Cap
X4 Pharmaceuticals has a market cap or net worth of $318.59 million as of November 13, 2026. It is the 17,511th most valuable company in the world and the 3,095th biggest in the United States. Its market cap has decreased by 5.85% in one year.
Market Cap
318.59M
Enterprise Value
208.09M
1-Year Change
-5.85%
Global Rank
Country Rank
#3,095 United States
Category
ChartMarket Cap Chart
Since March 14, 2019, X4 Pharmaceuticals's market cap has increased from $101.77M to $318.59M, an increase of 213.04%. That is a compound annual growth rate of 16.03%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 318.59M | -8.91% |
| Dec 31, 2025 | 349.75M | 179.54% |
| Dec 31, 2024 | 125.11M | -10.81% |
| Dec 29, 2023 | 140.27M | 16.23% |
| Dec 30, 2022 | 120.68M | 87.36% |
| Dec 31, 2021 | 64.41M | -38.49% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 14, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ProKidney | 341.62M |
| Atea Pharmaceuticals | 338.88M |
| Enanta Pharmaceuticals | 337.85M |
| Galectin Therapeutics | 331.80M |
| Benitec Biopharma | 330.34M |
| Autolus Therapeutics | 328.71M |
| Inhibikase Therapeutics | 327.37M |
| Agenus | 326.68M |